92 results

• Nephrogenic Systemic Fibrosis Settlements Reached by Bayer in 140 Cases

  March 4, 2010

  Staff Writers

  Bayer reports that it has reached settlement agreements with nearly half of the plaintiffs who have filed a Magnevist lawsuit,...

• GE Healthcare Settles Libel Lawsuit Over Omniscan with Radiologist

  February 23, 2010

  Staff Writers

  GE Healthcare and a Danish scientist have reached a settlement in a libel lawsuit over statements made about the side...

• Radiologist Fights Back Against GE Healthcare Over Omniscan Side Effects

  February 19, 2010

  Staff Writers

  A Danish scientist is filing a counterclaim against GE Healthcare in response to libel charges originally brought by the company...

• Nephrogenic Systemic Fibrosis Lawsuit Scheduled For Trial in San Francisco

  December 10, 2009

  AboutLawsuits

  A date has been set for the start of what could be the first trial of a lawsuit involving nephrogenic...

• Nephrogenic Systemic Fibrosis Risk 77 Times Higher Among Dialysis Patients

  November 17, 2009

  AboutLawsuits

  The results of a new study into side effects of gadolinium MRI contrast agents indicates that patients undergoing dialysis are...

• Optimark MRI Contrast Agent NSF Warning Updated

  November 10, 2009

  AboutLawsuits

  The makers of Optimark, a gadolinium-based MRI contrasting agent, are changing the warning label to indicate that Optimark should not...

• Nephrogenic Systemic Fibrosis Warnings to be Reviewed Again by FDA

  October 19, 2009

  AboutLawsuits

  An FDA advisory committee is planning to review a decision by the agency to place the same warning on all...

• Nephrogenic Systemic Fibrosis Settlements Being Negotiated on Bayer Magnevist Lawsuits

  March 16, 2009

  AboutLawsuits

  According to U.S. District Judge Dan Polster, Bayer Healthcare has initiated settlement negotiations with a number of plaintiffs who have...

• Gadolinium Litigation Judge May Not Preside Over First Trials

  February 10, 2009

  AboutLawsuits

  The federal judge overseeing the consolidated Gadolinium litigation involving cases filed on behalf of those who have developed Nephrogenic Systemic...

• Gadolinium MRA Contrast Agent Approved by FDA with Warnings about Nephrogenic Systemic Fibrosis

  December 30, 2008

  AboutLawsuits

  The FDA has approved a new gadolinium-based contrast agent, Vasovist Injection, which is the first imaging agent approved for use...